Aigen Investment Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Aigen Investment Management’s Portfolio PGNX Stock Details PGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-6,931	Closed	-$26K	–	1455
2020 Q1	$26K	Sell	6,931 -6,393	-48%	-$27.5K	﹤0.01%	1070
2019 Q4	$68K	Buy	+13,324	New	+$70.5K	0.01%	760

Other funds holding PGNX

ECM

Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Aigen Investment Management's PGNX Position: Q2 2020 in Review

Aigen Investment Management sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 6,931 shares — an estimated $26K sold.

Aigen Investment Management first reported a position in PGNX in Q4 2019 and held it in 2 quarters. The position peaked at $68K in Q4 2019. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

Aigen Investment Management reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
Aigen Investment Management sold 6,931 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $26K.
Aigen Investment Management first reported a position in Progenics Pharmaceuticals Inc in Q4 2019 and held it in 2 quarters.
Aigen Investment Management's Progenics Pharmaceuticals Inc position peaked at $68K in Q4 2019.
3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on Aigen Investment Management's 13F filing for Q2 2020, filed 10 Aug 2020.